Literature DB >> 18560848

Comparison of surgical and conservative treatment for degenerative lumbar scoliosis.

Torsten Kluba1, Gülden Dikmenli, Klaus Dietz, Johannes P Giehl, Thomas Niemeyer.   

Abstract

INTRODUCTION: Demographic changes create an expansion of the elderly population segment of society. Demands of mobility and quality of life have increased in this age group over the last decades. A rising number of elderly patients suffering from degenerative "de novo" lumbar scoliosis (DLS) may be eligible for surgical options to treat their spinal deformities. Therefore, we compared the clinical and radiographic results of conservative and surgical treatment.
MATERIALS AND METHODS: During 1990-2003, 55 patients with DLS were treated and followed up for a minimum of 24 months. Group 1 patients (n=26) underwent surgery (decompression and spondylodesis), group 2 patients (n=29) declined surgery and received conservative treatment (analgesics, physiotherapy). Clinical data, theatre records and X-rays were analysed. All patients were contacted and 73.1% of group 1 and 75.8% of group 2 patients were clinically re-evaluated and received standing radiographs on average 4.8 and 3.8 years after the initial procedure or consultation, respectively.
RESULTS: We found a significantly higher rate of spinal stenosis and degenerative spondylolisthesis in group 1 patients (P<0.01). The procedure corrected the lumbar deformity in the frontal and sagittal planes. Three patients required revision for implant failure. Walking distance improved significantly during the postoperative course. Analgesic requirement decreased in comparison to group 2 patients. No significant difference was evident between the groups in terms of lumbar back pain after 3.8 and 4.8 years, respectively.
CONCLUSION: Operative treatment of DLS with decompression in combination with a longer fusion improved walking ability and quality of life. Reduced need of analgesics can be anticipated. Benefits of surgery and risks of complications have to be considered carefully to avoid disappointment in expectations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560848     DOI: 10.1007/s00402-008-0673-z

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  7 in total

1.  Surgical treatments for degenerative lumbar scoliosis: a meta analysis.

Authors:  Guohua Wang; Jianzhong Hu; Xiangyang Liu; Yong Cao
Journal:  Eur Spine J       Date:  2015-04-22       Impact factor: 3.134

2.  Adults with idiopathic scoliosis improve disability after motor and cognitive rehabilitation: results of a randomised controlled trial.

Authors:  Marco Monticone; Emilia Ambrosini; Daniele Cazzaniga; Barbara Rocca; Lorenzo Motta; Cesare Cerri; Marco Brayda-Bruno; Alessio Lovi
Journal:  Eur Spine J       Date:  2016-03-25       Impact factor: 3.134

Review 3.  The importance of sagittal balance in adult scoliosis surgery.

Authors:  Jason Pui Yin Cheung
Journal:  Ann Transl Med       Date:  2020-01

4.  Abnormalities of the lumbar spine in the coronal plane on plain abdominal radiographs.

Authors:  Michael Kilshaw; Richard P Baker; Richard Gardner; Sebastian Charosky; Ian Harding
Journal:  Eur Spine J       Date:  2010-11-11       Impact factor: 3.134

5.  Effects of transforaminal injection for degenerative lumbar scoliosis combined with spinal stenosis.

Authors:  Hee-Seung Nam; Yong Bum Park
Journal:  Ann Rehabil Med       Date:  2011-08-31

6.  Analysis of the Functional and Radiological Outcomes of Lumbar Decompression without Fusion in Patients with Degenerative Lumbar Scoliosis.

Authors:  Akshay Dharamchand Gadiya; Mandar Deepak Borde; Nishant Kumar; Priyank Mangaldas Patel; Premik Bhupendra Nagad; Shekhar Yeshwant Bhojraj
Journal:  Asian Spine J       Date:  2019-07-30

7.  Predictive factors for successful non-operative treatment and achieving MCID improvement in health-related quality of life in adult spinal deformity.

Authors:  Jason Pui Yin Cheung; Hei Lung Wong; Prudence Wing Hang Cheung
Journal:  BMC Musculoskelet Disord       Date:  2022-08-22       Impact factor: 2.562

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.